Glasgow Alcoholic Hepatitis Score (GAHS)
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
حداقل ۱ — حداکثر ۱۰۰ • واحد: ×10⁹/L
حداقل ۱ — حداکثر ۵۰ • واحد: mmol/L
حداقل ۰.۸ — حداکثر ۱۰ • واحد: ratio
حداقل ۱۰ — حداکثر ۱۰۰۰ • واحد: μmol/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk5–8
- High Risk9–12
The Glasgow Alcoholic Hepatitis Score (GAHS) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include age. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Prognostic score for mortality prediction in patients with alcoholic hepatitis using five clinical variables: age, white blood cell count, urea, prothrombin time ratio, and bilirubin. More accurate than the modified Discriminant Function for predicting 28-day mortality
Clinical Indication
The Glasgow Alcoholic Hepatitis Score (GAHS) is indicated for bedside clinical practice to support Prognostic score for mortality prediction in patients with alcoholic hepatitis using five clinical variables: age, white blood cell count, urea, prothrombin time ratio, and bilirubin. More accurate than the modified Discriminant Function for predicting 28-day mortality. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration. Clinical exclusion: Consider contraindications to corticosteroids before treatment initiation.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Sensitivity: 81% (day 1), 93% (day 7); Specificity: 61% (day 1), 68% (day 7).
Score = Age points + WBC points + Urea points + PT ratio points + Bilirubin points. Total range: 5-12 points. Cutoff: ≥9 indicates high mortality risk
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient age in years(years) |
| white_cell_count | float | Yes | White blood cell count(×10⁹/L) |
| urea | float | Yes | Blood urea nitrogen (BUN). Urea was chosen over creatinine as marker of renal function to avoid interference from hyperbilirubinaemia(mmol/L) |
| prothrombin_time_ratio | float | Yes | Prothrombin time ratio (PT ratio) or INR. Reflects synthetic liver function and coagulopathy(ratio) |
| bilirubin | float | Yes | Serum total bilirubin level. Major marker of hepatic dysfunction in alcoholic hepatitis(μmol/L) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 5–8 | Low Risk | Good prognosis |
| 9–12 | High Risk | Poor prognosis |
Evidence-Based References (EBM)
- Forrest EH, Evans CD, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54(8):1174-1179. doi: 10.1136/gut.2004.050781.DOI: 10.1136/gut.2004.050781
- Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45(6):1348-1354. doi: 10.1002/hep.21607.DOI: 10.1002/hep.21607
- Forrest EH, Morris AJ, Stewart S, et al. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut. 2007;56(12):1743-1746. doi: 10.1136/gut.2006.099226.DOI: 10.1136/gut.2006.099226